Cargando…
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
There is an increasing need to evaluate innovative drugs for childhood cancer using combination strategies. Strong biological rationale and clinical experience suggest that multiple agents will be more efficacious than monotherapy for most diseases and may overcome resistance mechanisms and increase...
Autores principales: | Moreno, Lucas, DuBois, Steven G., Glade Bender, Julia, Mauguen, Audrey, Bird, Nick, Buenger, Vickie, Casanova, Michela, Doz, François, Fox, Elizabeth, Gore, Lia, Hawkins, Douglas S., Izraeli, Shai, Jones, David T.W., Kearns, Pamela R., Molenaar, Jan J., Nysom, Karsten, Pfister, Stefan, Reaman, Gregory, Smith, Malcolm, Weigel, Brenda, Vassal, Gilles, Zwaan, Christian Michel, Paoletti, Xavier, Iasonos, Alexia, Pearson, Andrew D.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414747/ https://www.ncbi.nlm.nih.gov/pubmed/37015036 http://dx.doi.org/10.1200/JCO.22.02430 |
Ejemplares similares
-
Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE
por: de Rojas, Teresa, et al.
Publicado: (2021) -
Deciphering “B-others”: Novel fusion genes driving B-cell acute lymphoblastic leukemia
por: Izraeli, Shai
Publicado: (2016) -
The first achievement of complete remission in childhood leukemia by treatment with the folic acid antagonist aminopterin
por: Izraeli, Shai
Publicado: (2022) -
Opportunities and challenges of personalized therapy of patients with HR ALL
por: Izraeli, Shai
Publicado: (2019) -
A reconstructed melanoma data set for evaluating differential treatment benefit according to biomarker subgroups
por: Satagopan, Jaya M., et al.
Publicado: (2017)